Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small-cell lung cancer and enhance the efficacy of platinum-based chemotherapy.
Anqi LinWeiming MouLingxuan ZhuTao YangChaozheng ZhouJian ZhangPeng LuoPublished in: Cancer innovation (2023)
DNA polymerase binding pathway mutations can be used as prognostic markers for platinum-based chemotherapy in SCLC.